Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells of patients with scleroderma, an incurable and life-threatening autoimmune disease, a new study shows. Scleroderma is a chronic disease that affects the immune system, causing a buildup of scar-like tissues in the skin and internal organs known as fibrosis. This process...